The FDA has granted Fast Track designation to invobenitug, an investigational anti-cDPP3 monoclonal antibody designed to restore RAAS balance in cardiogenic shock.
TEEN4 Pharmaceuticals GmbH today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to invobenitug (formerly known as procizumab), for the treatment of ...
In the prehospital setting, hemodynamic instability presents a major diagnostic challenge for emergency medical teams, as rapid differentiation between underlying causes is often required in the ...
Ferrari has been the talk of Formula 1 pre-season testing this week with its innovative updates to the SF-26. First, on Wednesday, Motorsport.com reported that the Italian outfit had placed a small ...
Cardiogenic shock remains a highly lethal condition, with early mortality approaching 50% despite advances in contemporary care. A recent review in The New England Journal of Medicine underscored the ...
The survival benefit associated with the use of Impella CP (Abiomed) for patients with STEMI-related cardiogenic shock in the DanGer Shock trial progressively shrank as the time between symptom onset ...
Cardiogenic shock (CS) is a state of decreased cardiac output leading to systemic hemodynamic collapse and potential end-organ damage with an elevated risk of mortality. CS represents a heterogenous ...
“Anaphylactic shock is the most severe form of anaphylaxis,” says Inderpal Randhawa, MD, a board-certified allergist and pulmonologist and the founder of the Food Allergy Institute in Long Beach, ...
Madrid, Spain – 31 August 2025: Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results